NASDAQ: AXGN - AxoGen

Yield per half year: +11.51%
Dividend yield: 0.00%
Sector: Healthcare

Share chart AxoGen

Extended chart Simple chart
Financial Markets by TradingView

About AxoGen

AxoGen — разработчик хирургических решений, в том числе трансплантатов тканей человека, базируется в Алачуа, Флорида. Продукция Axogen предназначена для лечения повреждений периферических нервов. В 2013 году компания привлекла 18 миллионов долларов в ходе первичного публичного размещения акций.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1990-03-27
ISIN US05463X1063
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 32.79
Дивиденд ао 1
Сайт http://www.axogeninc.com
Цена ао 18.99
Change price per day: +0.5696% (15.8)
Change price per week: -2.03% (16.22)
Change price per month: -8.94% (17.45)
Change price per 3 month: -11.97% (18.05)
Change price per half year: +11.51% (14.25)
Change price per year: +120.39% (7.21)
Change price per 3 year: +115.9% (7.36)
Change price per 5 year: +24.82% (12.73)
Change price per 10 year: +233.82% (4.76)
Change price per year to date: -3.58% (16.48)
All parameters

Underestimation

Title Value Grade
P/S 3.9 4
P/BV 7.02 1
P/E 0 0
EV/EBITDA 126.82 1
Total: 2.25

Efficiency

Title Value Grade
ROA, % -4.98 0
ROE, % -9.99 0
Total: 0.1667

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.8333 8.33
Total: 2.62

Debt

Title Value Grade
Debt/EBITDA 11.3 0
Total: 5.8

Growth impulse

Title Value Grade
Yield Revenue, % 66.82 8
Yield Ebitda, % -130.7 0
Yield EPS, % -61.38 0
Total: 1.6
More

Institutions Volume Share, %
ArrowMark Colorado Holdings LLC 5152300 11.79
Blackrock Inc. 3342773 7.65
Morgan Stanley 3082437 7.06
Soleus Capital Management, L.P. 2595815 5.94
Vanguard Group Inc 2465496 5.64
Millennium Management LLC 1488720 3.41
DAFNA Capital Management, LLC 935894 2.14
Geode Capital Management, LLC 896336 2.05
Perceptive Advisors LLC 808380 1.85
State Street Corporation 792087 1.81



Head Job title Payment Year of birth
Ms. Doris Quackenbush Vice President of Sales N/A
Mr. Marc A. Began Executive VP, General Counsel & Chief Compliance Officer N/A 1968 (57 years)
Mr. Jens Schroeder Kemp Chief Marketing Officer N/A
Mr. Erick DeVinney Chief Innovation Officer N/A 1976 (49 years)
Mr. Harold D. Tamayo Vice President of Finance & Investor Relations N/A
Dr. Ivica Ducic M.D., Ph.D. Chief Medical Officer N/A
Mr. Todd Puckett Vice President of Operations
Ms. Karen Zaderej Advisor 1962 (63 years)

Address: United States, Alachua, FL , 13631 Progress Boulevard - open in Google maps, open in Yandex maps
Website: http://www.axogeninc.com